Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim

Clinical trial NCT01143038 · COMPLETED

Trial details

NCT number: NCT01143038
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Thrombocytopenic Purpura

Start date: 2010-11-30
Primary completion: 2013-09-20
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.